Changes

In such a case, an anxiolytic medication, such as an [[Selective Serotonine Reuptake Inhibitor Drugs|SSRI]] drug, can be used to facilitate desensitisation and counter-conditioning. This will reduce hyper vigilance and arousal so that the cat settles more quickly in the environment.

In such a case, an anxiolytic medication, such as an [[Selective Serotonine Reuptake Inhibitor Drugs|SSRI]] drug, can be used to facilitate desensitisation and counter-conditioning. This will reduce hyper vigilance and arousal so that the cat settles more quickly in the environment.

In the human behaviour field, psychoactive medication is extensively used in combination with cognitive and behavioural approaches to treat problems relating to fear, phobia and anxiety. In the veterinary behaviour field there are only a very few drugs which have been properly tested under controlled trials. For the majority of other medications there is minimal available data and information is extrapolated from use in the field of human psychiatry. When using drugs which are not licensed for veterinary use, it is important to consider that drug metabolism and effects vary between species. <ref name="Merck">Merck Veterinary Manual - [http://www.merckmanuals.com/vet/behavior.html Behaviour] (10th Edition) 2011 The Merck Publishing Group</ref>.

In the human behaviour field, psychoactive medication is extensively used in combination with cognitive and behavioural approaches to treat problems relating to fear, phobia and anxiety. In the veterinary behaviour field there are only a very few drugs which have been properly tested under controlled trials. For the majority of other medications there is minimal available data and information is extrapolated from use in the field of human psychiatry. When using drugs which are not licensed for veterinary use, it is important to consider that drug metabolism and effects vary between species. <ref name="Merck">Merck Veterinary Manual - [http://www.merckmanuals.com/vet/behavior.html Behaviour] (10th Edition) 2011 The Merck Publishing Group</ref>.